Advertisement
Screener

Haemonetics Corporation (HAE) Proceeds from Lines of Credit

2.6 / 5 stars · 48/93 Roast Me

Haemonetics Corporation Proceeds from Lines of Credit

Haemonetics Corporation (HAE) reported Proceeds from Lines of Credit of -$15.15 million for the 12-month period ending 2011-04-02, per its 10-K filed 2011-05-26.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromLinesOfCredit · last filed 2011-05-26

  • Haemonetics Corporation proceeds from lines of credit for the quarter ending 2011-04-02 was -$6.36M.
  • Haemonetics Corporation proceeds from lines of credit for the quarter ending 2011-01-01 was -$3.54M, a 20923.53% decline year-over-year.
  • Haemonetics Corporation proceeds from lines of credit for the quarter ending 2010-10-02 was $4.69M.
  • Haemonetics Corporation proceeds from lines of credit for the quarter ending 2010-07-03 was -$9.94M, a 160.20% decline year-over-year.
  • Haemonetics Corporation proceeds from lines of credit for fiscal 2011 was -$15.15M, a 345.04% decline from fiscal 2010.
  • Haemonetics Corporation proceeds from lines of credit for fiscal 2010 was $6.18M.
  • Haemonetics Corporation proceeds from lines of credit for fiscal 2009 was -$5.58M.
Period endProceeds from Lines of Credit 3 monthProceeds from Lines of Credit 6 monthProceeds from Lines of Credit 9 monthProceeds from Lines of Credit 12 month
2011-04-02-$6.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-05-26
-$9.90M
derived: sum of 2 quarters · filed 2011-05-26
-$5.22M
derived: sum of 3 quarters · filed 2011-05-26
-$15.15M
10-K · filed 2011-05-26
2011-01-01-$3.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-02-08
$1.15M
derived: sum of 2 quarters · filed 2011-02-08
-$8.79M
10-Q · filed 2011-02-08
-$16.20M
derived: sum of 4 quarters · filed 2011-05-26
2010-10-02$4.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-11-10
-$5.25M
10-Q · filed 2010-11-10
-$12.66M
derived: sum of 3 quarters · filed 2011-05-26
-$12.64M
derived: sum of 4 quarters · filed 2011-05-26
2010-07-03-$9.94M
10-Q · filed 2010-08-11
-$17.35M
derived: sum of 2 quarters · filed 2011-05-26
-$17.33M
derived: sum of 3 quarters · filed 2011-05-26
-$20.26M
derived: sum of 4 quarters · filed 2011-05-26
2010-04-03-$7.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-05-26
-$7.39M
derived: sum of 2 quarters · filed 2011-05-26
-$10.32M
derived: sum of 3 quarters · filed 2011-05-26
$6.18M
10-K · filed 2011-05-26
2009-12-26$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-02-08
-$2.91M
derived: sum of 2 quarters · filed 2011-02-08
$13.60M
10-Q · filed 2011-02-08
2009-09-26-$2.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-11-10
$13.58M
10-Q · filed 2010-11-10
2009-06-27$16.50M
10-Q · filed 2010-08-11
2009-03-28-$5.58M
10-K · filed 2011-05-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55